Utility of Presepsin (sCD14-ST) as a Diagnostic and Prognostic Marker of Sepsis in the Emergency Department

Clinica Chimica Acta - Netherlands
doi 10.1016/j.cca.2015.08.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Presepsin (sCD14-ST): Could It Be a Novel Marker for the Diagnosis of ST Elevation Myocardial Infarction?

Archives of Medical Science - Atherosclerotic Diseases
2017English

Role of Procalcitonin as a Diagnostic and Prognostic Marker of Infectious Diseases in the Emergency Department: Preliminary Data

Critical Care
Critical CareIntensive Care Medicine
2010English

Diagnostic Value of Presepsin in Sepsis

Biomarkers and Applications
2017English

Presepsin as a Sepsis Biomarker

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology
2018English

PD23-04 THE POTENTIAL UTILITY OF CHEMOKINE CXCL1 (GROα) AS a NOVEL DIAGNOSTIC AND PROGNOSTIC MARKER FOR BLADDER CANCER

Journal of Urology
Urology
2015English

Usefulness of the Thrombotic Microangiopathy Score as a Promising Prognostic Marker of Septic Shock for Patients in the Emergency Department

Journal of Clinical Medicine
2019English

Presepsin as a New Marker for Early Detection Neonatal Sepsis in Al-Quwayiyah General Hospital Riyadh, KSA

Journal of Advances in Microbiology
2020English

Neutrophil CD64 as a Diagnostic Marker of Sepsis: Impact on Neonatal Care

American Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2014English

Clinical Utility of Procalcitonin as a Marker of Sepsis: A Potential Predictor of Causative Pathogens

Internal Medicine
Internal MedicineMedicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy